Michael J. Borucki

832 total citations
22 papers, 632 citations indexed

About

Michael J. Borucki is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Michael J. Borucki has authored 22 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Michael J. Borucki's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (7 papers). Michael J. Borucki is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (7 papers). Michael J. Borucki collaborates with scholars based in United States, United Kingdom and Spain. Michael J. Borucki's co-authors include Tejinder S. Ahuja, James J. Grady, Srinivasan Rajaraman, Vahakn B. Shahinian, Juan P. Olano, A K Haque, William Hollander, Michelle Onorato, Cynthia Cole and Richard B. Pollard and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Michael J. Borucki

19 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Borucki United States 12 428 274 182 166 65 22 632
Jean–Baptiste Guiard–Schmid France 12 203 0.5× 159 0.6× 68 0.4× 69 0.4× 34 0.5× 26 392
Anthony B. Minnefor United States 13 213 0.5× 259 0.9× 58 0.3× 146 0.9× 19 0.3× 28 599
Manuel Fernández Guerrero Spain 13 257 0.6× 192 0.7× 78 0.4× 117 0.7× 7 0.1× 46 588
Jorge Luján‐Zilbermann United States 13 215 0.5× 324 1.2× 133 0.7× 79 0.5× 12 0.2× 25 633
Manuel Crespo Spain 16 647 1.5× 296 1.1× 266 1.5× 423 2.5× 42 0.6× 40 927
Michel Garré France 9 216 0.5× 169 0.6× 59 0.3× 108 0.7× 6 0.1× 18 472
Rakhi Kohli United States 10 347 0.8× 256 0.9× 103 0.6× 65 0.4× 10 0.2× 19 602
Hadewych J. M. ter Hofstede Netherlands 9 732 1.7× 241 0.9× 404 2.2× 367 2.2× 69 1.1× 15 1.0k
Ricardo Rabagliati Chile 11 318 0.7× 206 0.8× 231 1.3× 160 1.0× 6 0.1× 36 524
María Stella Mura Italy 16 394 0.9× 349 1.3× 148 0.8× 169 1.0× 230 3.5× 31 826

Countries citing papers authored by Michael J. Borucki

Since Specialization
Citations

This map shows the geographic impact of Michael J. Borucki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Borucki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Borucki more than expected).

Fields of papers citing papers by Michael J. Borucki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Borucki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Borucki. The network helps show where Michael J. Borucki may publish in the future.

Co-authorship network of co-authors of Michael J. Borucki

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Borucki. A scholar is included among the top collaborators of Michael J. Borucki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Borucki. Michael J. Borucki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borucki, Michael J., Mark Holodniy, Gerald Pierone, et al.. (2006). The Safety and Tolerability of Z-100 in Patients Infected with HIV-1. Antiviral Therapy. 11(3). 297–303.
2.
Rodríguez‐Torres, M., Francesca J. Torriani, Vincent Soriano, et al.. (2005). Effect of Ribavirin on Intracellular and Plasma Pharmacokinetics of Nucleoside Reverse Transcriptase Inhibitors in Patients with Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Results of a Randomized Clinical Study. Antimicrobial Agents and Chemotherapy. 49(10). 3997–4008. 32 indexed citations
3.
4.
5.
Baillargeon, Jacques, James J. Grady, & Michael J. Borucki. (2000). Immunologic Predictors of HIV-Related Survival among Texas Prison Inmates. AIDS Patient Care and STDs. 14(4). 183–187. 3 indexed citations
6.
Ahuja, Tejinder S., Michael J. Borucki, & James J. Grady. (2000). Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. American Journal of Kidney Diseases. 36(3). 574–580. 55 indexed citations
7.
Shahinian, Vahakn B., Srinivasan Rajaraman, Michael J. Borucki, et al.. (2000). Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. American Journal of Kidney Diseases. 35(5). 884–888. 86 indexed citations
8.
Baillargeon, Jacques, James J. Grady, & Michael J. Borucki. (1999). Immunological predictors of HIV-related survival. International Journal of STD & AIDS. 10(7). 467–470. 8 indexed citations
9.
Baillargeon, Jacques, Michael J. Borucki, & John Williamson. (1999). Temporal Trends in AIDS-Related Survival. AIDS Patient Care and STDs. 13(1). 17–22. 2 indexed citations
10.
Onorato, Michelle, Michael J. Borucki, Gwen Baillargeon, et al.. (1999). Risk Factors for Colonization or Infection Due to Methicillin-Resistant Staphylococcus Aureus in HIV-Positive Patients A Retrospective Case-Control Study. Infection Control and Hospital Epidemiology. 20(1). 26–30. 60 indexed citations
11.
Ahuja, Tejinder S., et al.. (1999). Is the Prevalence of HIV-Associated Nephropathy Decreasing?. American Journal of Nephrology. 19(6). 655–659. 72 indexed citations
12.
13.
Gnann, John W., Clyde S. Crumpacker, Jacob Lalezari, et al.. (1998). Sorivudine versus Acyclovir for Treatment of Dermatomal Herpes Zoster in Human Immunodeficiency Virus-Infected Patients: Results from a Randomized, Controlled Clinical Trial. Antimicrobial Agents and Chemotherapy. 42(5). 1139–1145. 41 indexed citations
14.
Lyons, Barbara, et al.. (1997). HIV Manual for Health Care Professionals. The Nurse Practitioner. 22(5). 198–198. 3 indexed citations
15.
Valentine, Fred, Patrick Haslett, David Katzenstein, et al.. (1996). A Randomized, Placebo-Controlled Study of the Immunogenicity of Human Immunodeficiency Virus (HIV) rgp160 Vaccine in HIV-Infected Subjects with >=400/mm3 CD4 T Lymphocytes (AIDS Clinical Trials Group Protocol 137). The Journal of Infectious Diseases. 173(6). 1336–1346. 41 indexed citations
16.
Olano, Juan P., et al.. (1995). Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving Zidovudine. Clinical Infectious Diseases. 21(4). 973–976. 88 indexed citations
17.
Muma, Richard D., Barbara A. Lyons, Michael J. Borucki, & Richard B. Pollard. (1994). HIV manual for health care professionals. 1st edition.. Holmes Museum Of Anthropology (Wichita State University). 1 indexed citations
18.
Clench, Mary H., et al.. (1993). Clostridium difficile Diarrhea in Patients with AIDS Versus Non-AIDS Controls Methods of Treatment and Clinical Response to Treatment. Journal of Clinical Gastroenterology. 16(3). 192–194. 25 indexed citations
19.
Levin, H S, D. H. Williams, Michael J. Borucki, et al.. (1990). Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection.. PubMed. 3(8). 757–62. 42 indexed citations
20.
Borucki, Michael J., et al.. (1988). Tremor Induced by Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome (AIDS). Annals of Internal Medicine. 109(1). 77–78. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean–Baptiste Guiard–Schmid Breakdown of academic impact, for papers by Anthony B. Minnefor Breakdown of academic impact, for papers by Manuel Fernández Guerrero Breakdown of academic impact, for papers by Jorge Luján‐Zilbermann Breakdown of academic impact, for papers by Manuel Crespo Breakdown of academic impact, for papers by Michel Garré Breakdown of academic impact, for papers by Rakhi Kohli Breakdown of academic impact, for papers by Hadewych J. M. ter Hofstede Breakdown of academic impact, for papers by Ricardo Rabagliati Breakdown of academic impact, for papers by María Stella Mura
Rankless by CCL
2026